MAP Pharmaceuticals Employee Directory
Pharmaceutical ManufacturingUnited States51-200 Employees
MAP Pharmaceuticals is a United States–based pharmaceutical manufacturer focused on developing and bringing to market therapies for conditions that lack adequate treatment options. Its lead program, LEVADEX, is an inhaled therapy being developed for potential migraine treatment, and the company has reported positive efficacy results from the first Phase 3 trial. In addition, MAP pursues new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the benefits of proven drugs, drawing on their established safety, efficacy, and commercialization histories. The company operates in the pharmaceutical manufacturing sector, serving patients who need alternatives when existing medicines fall short. By concentrating on inhalation delivery and reformulation of established medicines, MAP positions itself at the intersection of drug delivery technology and therapeutic development. Based in the United States, it is a mid-sized enterprise focused on advancing therapies for unmet medical needs.